The Discounted Cash Flow (DCF) valuation of TG Therapeutics Inc (TGTX) is (12.59) USD. With the latest stock price at 38.92 USD, the upside of TG Therapeutics Inc based on DCF is -132.3%.
Based on the latest price of 38.92 USD and our DCF valuation, TG Therapeutics Inc (TGTX) is a sell. selling TGTX stocks now will result in a potential gain of 132.3%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.0% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (32.33) - (8.42) | (12.59) |
| Upside | -183.1% - -121.6% | -132.3% |